Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Yanjiao Yu (she/her/hers)
Tavotek Biotherapeutics
Poster(s):
(T1330-02-09) Preliminary Phase 1a Clinical Results of Multispecific Antibody TAVO412 in Patients with Hard-to-Treat Solid Tumors
Tuesday, May 6, 2025
1:30 PM – 2:30 PM
ET
